No definition available.
Arteriovenous malformation of peripheral vessels
Q17_ARTERIOVENOUS_MALFORMATION_OF_PERIPHERAL_VESSELS
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
215 |
4. Check minimum number of eventsNone |
215 |
5. Include endpointsNone |
215 |
6. Filter based on genotype QC (FinnGen only) |
201 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Arteriovenous malformation of peripheral vessels
based on the number of shared cases.
Similar with more cases:
- Other congenital malformations of peripheral vascular system
- Congenital malformations of the circulatory system
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities, including avohilmo
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 201 | 131 | 70 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.03 |
| Median age at first event (years) | 44.80 | 44.07 | 46.16 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 206
- Matched controls
- 2060
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q27.3
ICD-10 Finland
Peripheral arteriovenous malformation
+∞
294.9
205
*
D18.0
ICD-10 Finland
Haemangioma, any site
33.2
84.7
58
24
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
14.7
51.2
51
45
Q27.4
ICD-10 Finland
Congenital phlebectasia
394.6
33.9
33
*
XX6KT
NOMESCO Finland
Other sclerotherapy
+∞
26.6
25
*
Q27.9
ICD-10 Finland
Congenital malformation of peripheral vascular system, unspecified
+∞
26.6
25
*
PG1HT
NOMESCO Finland
Extensive endovascular embolisation of arterio-venous malformation not elsewhere classified
+∞
22.3
21
*
QX3LT
NOMESCO Finland
Subcutaneous sclerotherapy
244.9
22.0
22
*
PG1JT
NOMESCO Finland
Very extensive endovascular embolisation of arterio-venous malformation not elsewhere classified
+∞
19.0
18
*
XX4BW, ,
NOMESCO Finland
172.6
15.7
16
*
PG1GT
NOMESCO Finland
Endovascular embolisation of arterio-venous malformation with radiological guidance not elsewhere classified
+∞
14.8
14
*
Q27.88
ICD-10 Finland
Other specified congenital malformation of peripheral vascular system
160.9
14.7
15
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
14.0
70
276
2280A
ICD-9 Finland
Haemangioma and lymphangioma, any site, Haemangioma, any site
138.1
12.6
13
*
D18.1
ICD-10 Finland
Lymphangioma, any site
+∞
11.6
11
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.5
11.4
47
162
JN5LT
NOMESCO Finland
Sclerotherapy with direct puncture body area
+∞
10.5
10
*
PG1CG
NOMESCO Finland
Extensive MRI examination of vasculature with high intensity magnet not elsewhere classified
+∞
10.5
10
*
I77.0
ICD-10 Finland
Arteriovenous fistula, acquired
104.6
9.5
10
*
Q82.50
ICD-10 Finland
Naevus flammeus
+∞
9.4
9
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
9.1
89
483
22700
ICD-8 Finland
Haemangioma and lymphangioma, Haemangioma
52.3
8.8
10
*
Q87.21
ICD-10 Finland
Klippel-Trénaunay-Weber syndrome
+∞
8.4
8
*
QX3KT, ,
NOMESCO Finland
+∞
8.4
8
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.1
7.8
36
132
I78.0
ICD-10 Finland
Hereditary haemorrhagic telangiectasia
46.8
7.8
9
*
Q27.2
ICD-10 Finland
Other congenital malformations of renal artery
83.0
7.5
8
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
9.9
7.4
14
15
PA5AC
NOMESCO Finland
Angiography of arteries to the face with X-ray
+∞
7.3
7
*
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
+∞
7.3
7
*
R4110
NOMESCO Finland
Physiotherapy
2.4
7.3
69
362
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
7.2
86
499
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
72.0
6.5
7
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.1
6.4
29
105
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
18.7
6.3
9
5
Z2221
NOMESCO Finland
Medical doctor
2.2
6.0
69
388
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
5.4
6.0
17
34
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
87
431
2.76
11.16
3.2
2.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
13
7
19.70
9.05
1.1
1.1
118.31
105.29
%
—
13
7
77
416
2.36
7.70
4.1
1.8
1.22
0.98
mg/l
0.29
61
325
12
13
9.72
6.38
2.8
2.9
100.00
100.46
%
0.01
12
13
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
32
5.33
5.70
3.5
6.7
0.28
0.35
iu/ml
—
9
23
119
861
1.90
4.84
4.0
2.8
—
—
estimate
—
0
0
68
412
1.97
4.70
4.7
2.4
2.47
2.73
mg/l
0.50
58
370
14
32
4.62
4.53
1.8
1.2
2.38
1.36
u/ml
—
8
14
14
33
4.47
4.41
1.4
1.1
—
—
—
0
0
131
1011
1.81
4.02
6.9
5.7
6.28
6.44
mmol/l
0.44
123
934
134
1058
1.76
3.63
12.1
10.5
3.86
3.97
e9/l
0.19
120
917
7
10
7.20
3.39
1.4
1.7
8.71
11.40
umol/l
—
7
10
83
583
1.71
3.37
4.4
3.1
2.34
2.36
mmol/l
0.49
77
532
98
725
1.67
3.25
7.7
5.1
35.73
36.75
g/l
0.82
93
696
28
142
2.12
3.08
4.0
3.0
—
—
—
0
0
67
454
1.71
3.05
2.7
3.0
0.67
0.29
e6/l
0.42
46
320
13
46
2.95
2.98
1.3
1.5
204.00
137.73
au/ml
—
5
11
105
803
1.63
2.97
10.3
8.4
1.22
1.22
mmol/l
0.47
87
705
13
47
2.88
2.87
1.2
1.4
—
—
—
0
0
13
47
2.88
2.87
1.3
1.5
—
—
—
0
0
196
1805
2.77
2.70
20.8
13.2
24.39
20.83
mg/l
0.74
162
1448
176
1564
1.86
2.57
25.5
16.8
13.84
13.43
%
2.48
176
1548
5
7
7.28
2.56
1.0
1.3
—
—
—
0
0
36
214
1.83
2.54
15.6
8.9
104.47
104.50
mmol/l
0.01
36
214
93
714
1.55
2.46
10.8
8.4
1.22
1.22
mmol/l
0.09
84
670
15
64
2.45
2.45
6.1
7.8
1.33
1.26
mg/l
0.14
15
58
17
77
2.32
2.45
1.4
1.5
—
—
—
0
0
12
47
2.65
2.31
1.3
1.6
—
—
—
0
0
5
9
5.66
2.22
1.0
1.0
—
—
—
0
0
43
281
1.67
2.19
2.3
2.8
0.62
0.81
e6/l
0.30
23
135
6
14
4.38
2.16
1.0
1.1
—
—
—
0
0
11
43
2.64
2.11
1.4
1.6
266.67
233.67
u/ml
—
6
18
72
537
1.52
2.11
2.4
2.6
54.05
66.56
u/l
0.80
65
506
16
77
2.17
2.02
1.2
1.4
—
—
—
0
0
6
16
3.83
1.95
1.0
1.2
—
—
—
0
0
6
17
3.60
1.85
1.0
1.2
—
—
—
0
0
39
262
1.60
1.78
2.3
2.8
1.69
2.89
e6/l
0.66
16
116
77
600
1.45
1.77
3.4
3.1
30.01
22.76
ng/l
0.29
49
347
43
298
1.56
1.73
1.8
1.6
475.06
44487139.14
pmol/l
0.50
32
263
198
1889
2.24
1.67
14.7
11.0
24.64
26.99
u/l
1.92
192
1847
6
19
3.22
1.67
1.0
1.4
—
—
—
0
0
21
121
1.82
1.66
1.5
1.3
—
32.31
—
0
9
45
319
1.53
1.63
2.5
2.5
2.41
2.44
mmol/l
0.77
40
284
6
20
3.06
1.59
1.0
1.4
—
—
—
0
0
6
20
3.06
1.59
1.0
1.4
—
—
—
0
0
6
20
3.06
1.59
1.0
1.4
—
—
—
0
0
22
131
1.76
1.57
4.5
2.8
77.89
69.83
ml/min/173m2
—
9
52
8
33
2.48
1.55
1.3
1.2
—
—
—
0
0
11
51
2.22
1.53
1.8
1.3
362.40
324.42
ug/g
—
5
29
18
102
1.84
1.50
2.9
1.6
0.36
0.33
mg/l
—
6
49
22
133
1.73
1.50
2.9
2.4
34.38
17.30
au/ml
—
5
10
57
433
1.44
1.47
2.6
2.8
323.14
322.67
umol/l
0.01
51
392
7
28
2.55
1.46
2.0
1.3
—
—
—
0
0
110
936
1.38
1.46
5.3
3.3
113.59
90.21
ug/l
0.45
99
890
6
22
2.78
1.44
1.0
1.3
—
—
—
0
0
157
1422
1.44
1.40
4.6
4.4
14.57
14.60
pmol/l
0.04
151
1320
18
105
1.78
1.38
2.2
1.6
—
—
—
0
0
6
23
2.66
1.37
1.0
1.3
—
—
—
0
0
26
170
1.61
1.34
1.8
2.0
—
—
—
0
0
0
41
0.00
1.32
0.0
2.1
—
71.04
—
0
17
9
43
2.14
1.32
1.2
1.2
—
—
—
0
0
32
223
1.51
1.26
4.7
2.8
5.85
7.62
umol/l
0.46
27
195
9
45
2.04
1.25
3.3
3.1
22.96
24.46
mmol/l
—
9
45
179
1674
1.53
1.24
5.3
5.3
1.94
1.85
mu/l
0.37
171
1563
94
797
1.33
1.21
3.2
2.7
75.05
73.17
nmol/l
0.31
85
729
8
39
2.09
1.16
1.9
1.6
—
—
—
0
0
36
264
1.44
1.12
1.6
2.0
1.37
1.34
%
0.11
31
238
59
472
1.35
1.11
1.7
1.7
—
—
—
0
0
111
975
1.30
1.07
3.6
3.5
0.00
0.00
estimate
-0.00
23
199
5
22
2.30
1.04
2.4
1.5
—
—
—
0
0
7
34
2.10
1.04
1.4
1.4
—
—
—
0
0
185
1757
1.52
1.01
4.7
4.6
4.80
4.71
mmol/l
0.61
176
1668
146
1337
1.32
1.00
4.3
3.3
38.94
42.04
u/l
0.33
141
1280
0
29
0.00
0.98
0.0
1.1
—
10.41
—
0
12
112
993
1.28
0.97
3.6
3.5
0.00
0.00
estimate
-0.00
22
191
24
167
1.49
0.97
1.1
1.2
18.14
135.43
u/ml
—
7
64
9
51
1.80
0.96
2.0
1.5
—
—
—
0
0
6
27
2.26
0.94
1.8
1.4
—
—
—
0
0
6
27
2.26
0.94
1.8
1.4
—
—
—
0
0
9
52
1.76
0.93
2.8
1.7
—
—
—
0
0
176
1662
1.40
0.93
3.8
3.9
1.20
1.28
mmol/l
1.08
167
1557
6
28
2.18
0.92
2.0
2.5
17.68
17.53
%
—
6
28
14
87
1.65
0.90
3.5
6.6
0.65
0.60
%
0.25
14
87
40
312
1.35
0.89
3.2
3.2
24.44
230.80
ng/l
1.16
27
205
8
43
1.89
0.88
1.1
1.3
—
—
—
0
0
6
30
2.03
0.87
2.2
1.5
—
—
—
0
0
13
80
1.67
0.87
1.6
1.6
—
—
—
0
0
18
121
1.53
0.86
22.4
12.8
26.16
25.12
mmol/l
0.60
18
121
14
89
1.61
0.83
3.5
6.5
1.57
1.39
%
0.17
14
89
8
47
1.73
0.81
3.8
2.7
—
—
—
0
0
8
47
1.73
0.81
2.1
1.4
—
—
—
0
0
109
981
1.24
0.77
3.7
3.5
0.00
0.00
estimate
-0.00
24
198
7
40
1.78
0.72
2.7
1.5
—
—
—
0
0
176
1679
1.33
0.71
17.5
12.4
92.21
88.63
ml/min/173m2
1.38
159
1522
7
41
1.73
0.70
2.1
1.5
—
—
—
0
0
27
206
1.36
0.70
2.2
2.1
—
—
—
0
0
33
263
1.30
0.65
2.4
1.7
—
—
—
0
0
175
1674
1.30
0.64
4.2
4.4
5.73
5.79
mmol/l
0.26
166
1563
26
200
1.34
0.64
2.2
1.5
—
—
—
0
0
5
29
1.74
0.64
1.8
1.4
6.84
7.80
mmol/l
—
5
23
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
0
22
0.00
0.59
0.0
4.1
—
87.44
—
0
22
86
773
1.19
0.58
2.1
1.9
1.25
1.36
mmol/l
0.93
77
676
6
37
1.64
0.56
3.2
1.8
—
—
—
0
0
143
1347
1.20
0.56
5.5
4.2
10.44
9.87
mm/h
0.17
138
1270
144
1358
1.20
0.55
3.3
3.6
—
—
—
0
0
26
206
1.30
0.54
2.0
1.6
1150.64
1164.54
nmol/l
0.02
14
158
24
191
1.29
0.49
2.3
1.6
—
—
—
0
0
59
521
1.19
0.48
4.2
3.5
0.00
0.01
estimate
0.50
23
184
181
1755
1.26
0.45
4.7
4.6
1.50
1.47
mmol/l
0.53
172
1656
169
1629
1.21
0.44
5.0
5.5
36.91
38.31
mmol/mol
1.74
161
1558
5
31
1.63
0.43
1.2
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
3.6
—
19.74
—
0
18
77
705
1.15
0.39
2.2
2.0
95.14
99.00
pmol/l
0.30
46
365
53
473
1.16
0.38
1.8
1.6
20.03
20.90
nmol/l
0.18
48
413
6
41
1.48
0.36
1.2
2.3
—
—
—
0
0
30
258
1.19
0.33
1.6
2.1
3.60
3.47
ratio
0.20
25
211
7
57
1.24
0.29
1.1
1.1
—
—
—
0
0
10
77
1.31
0.26
1.6
1.6
—
—
—
0
0
16
132
1.23
0.26
1.3
1.3
—
—
—
0
0
5
71
0.70
0.26
1.4
1.6
—
—
—
0
0
41
371
1.13
0.25
1.3
1.3
13.17
7.16
u/ml
0.26
18
143
9
77
1.18
0.24
1.1
1.2
—
—
—
0
0
44
402
1.12
0.23
1.4
1.3
14.63
28.99
iu/ml
1.52
15
125
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
55.35
—
0
10
0
12
0.00
0.21
0.0
1.3
—
104.46
—
0
12
43
395
1.11
0.21
3.3
3.3
1128.04
785.79
ng/l
0.32
34
321
181
1779
1.14
0.21
5.2
5.1
2.88
2.80
mmol/l
0.58
173
1684
0
13
0.00
0.21
0.0
2.6
—
1.54
—
0
13
0
14
0.00
0.20
0.0
1.2
—
221.56
—
0
14
7
58
1.21
0.18
1.1
1.1
—
—
—
0
0
21
186
1.14
0.17
3.6
4.4
33.50
32.18
%
0.25
16
122
8
70
1.15
0.16
9.1
4.6
24.81
24.52
mmol/l
—
8
70
8
73
1.10
0.16
1.1
1.2
—
—
—
0
0
24
219
1.11
0.13
2.7
2.8
0.72
0.78
ug/l
0.16
16
127
45
426
1.07
0.12
3.0
3.4
1.02
1.02
kg/l
0.48
26
264
13
115
1.14
0.11
1.0
1.0
—
—
—
0
0
10
87
1.16
0.09
13.9
12.8
26.42
24.67
mmol/l
—
10
82
49
511
0.95
0.09
1.4
1.4
1.31
1.42
u/ml
0.05
13
148
6
56
1.07
0.08
1.8
1.9
2.08
3.06
g/l
—
6
56
6
57
1.05
0.08
1.7
1.8
—
—
—
0
0
6
58
1.04
0.08
1.8
2.0
—
—
—
0
0
6
58
1.04
0.08
1.8
1.9
2.73
3.71
g/l
—
6
58
6
58
1.04
0.08
1.8
1.9
4.17
4.41
g/l
—
6
58
6
58
1.04
0.08
1.8
1.9
5.83
7.30
g/l
—
6
58
13
117
1.12
0.08
1.2
1.3
—
—
—
0
0
7
66
1.06
0.08
1.1
1.1
—
5.25
—
0
11
31
294
1.06
0.07
3.1
4.4
21.83
23.13
%
0.20
15
128
9
86
1.05
0.07
1.6
1.6
—
—
—
0
0
8
90
0.88
0.07
1.4
1.1
1.66
1.55
g/l
—
8
90
8
92
0.86
0.07
1.4
1.1
0.84
0.87
g/l
—
8
92
76
742
1.04
0.06
3.8
3.3
0.00
0.01
estimate
0.50
16
173
39
375
1.05
0.06
1.6
1.5
—
—
—
0
0
37
360
1.03
0.03
2.0
2.3
—
—
—
0
0
17
178
0.95
0.02
4.6
6.0
—
—
—
0
0
20
199
1.01
0.00
1.2
1.9
3.81
3.47
mmol/l
0.38
13
149
56
557
1.01
0.00
3.9
2.8
0.00
0.00
estimate
-0.00
16
166
50
505
0.99
0.00
5.2
4.0
5.06
9.21
mg/mmol
0.58
35
325
34
338
1.01
0.00
1.9
2.1
—
—
—
0
0
14
135
1.04
0.00
5.6
4.6
66.32
77.42
ng/l
0.36
14
126
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
81.38
—
0
8
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
8
85
0.94
-0.00
5.9
5.1
45.41
49.87
%
—
8
85
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
5.66
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
24.27
—
0
9
0
7
0.00
-0.00
0.0
3.7
—
20.34
—
0
7
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
67
0.89
-0.00
2.3
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
8.40
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_ARTERIOVENOUS_MALFORMATION_OF_PERIPHERAL_VESSELS – Arteriovenous malformation of peripheral vessels
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).